EMBECTA CORP. Financing Cash Flow
EMBECTA CORP. (EMBC) reported Financing Cash Flow of $19.30 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- EMBECTA CORP. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $112.40M.
- EMBECTA CORP. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$41.50M.
- EMBECTA CORP. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$51.60M.
- EMBECTA CORP. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$81.60M.
- EMBECTA CORP. net cash provided by (used in) financing activities for fiscal 2025 was -$226.70M.
- EMBECTA CORP. net cash provided by (used in) financing activities for fiscal 2024 was -$73.40M.
- EMBECTA CORP. net cash provided by (used in) financing activities for fiscal 2023 was -$48.70M.
- EMBECTA CORP. net cash provided by (used in) financing activities for fiscal 2022 was -$48.00M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $112.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $70.90M derived: sum of 2 quarters · filed 2026-08-07 | $19.30M 10-Q · filed 2026-08-07 | -$62.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$41.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$93.10M 10-Q · filed 2026-05-05 | -$174.70M derived: sum of 3 quarters · filed 2026-05-05 | -$237.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$51.60M 10-Q · filed 2026-02-05 | -$133.20M derived: sum of 2 quarters · filed 2026-02-05 | -$195.80M derived: sum of 3 quarters · filed 2026-08-07 | -$233.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$81.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$144.20M derived: sum of 2 quarters · filed 2026-08-07 | -$181.50M derived: sum of 3 quarters · filed 2026-08-07 | -$226.70M 10-K · filed 2025-11-25 |
| 2025-06-30 | -$62.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | -$99.90M derived: sum of 2 quarters · filed 2026-08-07 | -$145.10M 10-Q · filed 2026-08-07 | -$181.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$37.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$82.50M 10-Q · filed 2026-05-05 | -$119.10M derived: sum of 3 quarters · filed 2026-05-05 | -$130.60M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$45.20M 10-Q · filed 2026-02-05 | -$81.80M derived: sum of 2 quarters · filed 2026-02-05 | -$93.30M derived: sum of 3 quarters · filed 2026-02-05 | -$105.10M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | -$36.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$48.10M derived: sum of 2 quarters · filed 2025-11-25 | -$59.90M derived: sum of 3 quarters · filed 2025-11-25 | -$73.40M 10-K · filed 2025-11-25 |
| 2024-06-30 | -$11.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | -$23.30M derived: sum of 2 quarters · filed 2025-08-08 | -$36.80M 10-Q · filed 2025-08-08 | -$46.50M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | -$11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | -$25.30M 10-Q · filed 2025-05-09 | -$35.00M derived: sum of 3 quarters · filed 2025-11-25 | -$47.20M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | -$13.50M 10-Q · filed 2025-02-06 | -$23.20M derived: sum of 2 quarters · filed 2025-11-25 | -$35.40M derived: sum of 3 quarters · filed 2025-11-25 | -$56.10M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$21.90M derived: sum of 2 quarters · filed 2025-11-25 | -$42.60M derived: sum of 3 quarters · filed 2025-11-25 | -$48.70M 10-K · filed 2025-11-25 |
| 2023-06-30 | -$12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$32.90M derived: sum of 2 quarters · filed 2024-08-09 | -$39.00M 10-Q · filed 2024-08-09 | -$46.10M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | -$20.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | -$26.80M 10-Q · filed 2024-05-09 | -$33.90M derived: sum of 3 quarters · filed 2024-12-11 | -$30.60M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | -$6.10M 10-Q · filed 2024-02-09 | -$13.20M derived: sum of 2 quarters · filed 2024-12-11 | -$9.90M derived: sum of 3 quarters · filed 2024-12-11 | $80.40M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | -$3.80M derived: sum of 2 quarters · filed 2024-12-11 | $86.50M derived: sum of 3 quarters · filed 2024-12-11 | -$48.00M 10-K · filed 2024-12-11 |
| 2022-06-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $93.60M derived: sum of 2 quarters · filed 2023-08-08 | -$40.90M 10-Q · filed 2023-08-08 | -$113.10M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $90.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$44.20M 10-Q · filed 2023-05-12 | -$116.40M derived: sum of 3 quarters · filed 2023-11-29 | -$238.40M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | -$134.50M 10-Q · filed 2023-02-14 | -$206.70M derived: sum of 2 quarters · filed 2023-11-29 | -$328.70M derived: sum of 3 quarters · filed 2023-11-29 | -$442.10M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | -$72.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | -$194.20M derived: sum of 2 quarters · filed 2023-11-29 | -$307.60M derived: sum of 3 quarters · filed 2023-11-29 | -$417.10M 10-K · filed 2023-11-29 |
| 2021-06-30 | -$122.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | -$235.40M derived: sum of 2 quarters · filed 2022-08-15 | -$344.90M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | -$113.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$222.90M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | -$109.50M 10-Q · filed 2022-03-16 | |||
| 2020-09-30 | -$456.60M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |